Credit: UCLA Jonsson Comprehensive Cancer Center
This figure shows the expression of NY-ESO-1 increases after decitabine treatment.
The left side shows a melanoma cell line that normally expresses NY-ESO-1.
The middle section shows upregulated expression of NY-ESO-1 in T98 glioma cells after treatment with decitabine.
The right side shows the expression of NY-ESO-1 in T98 glioma cells without decitabine treatment.